Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_402	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	110% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_403	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_404	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	118% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_405	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	39% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_406	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	98% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_407	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	42% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_408	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	78% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_409	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_410	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	30% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_411	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_412	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_413	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_414	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	35% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_415	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	35% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_416	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_417	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_418	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_419	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	21% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_420	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_421	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_422	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_423	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_424	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	8% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_425	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_426	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	110% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_427	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_428	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	130% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_429	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_430	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	116% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_431	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	51% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_432	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	100% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_433	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_434	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_435	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_436	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_437	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovarian serous adenocarcinoma cell line	OVCAR3	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	40% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_438	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	88% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_439	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	46% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_440	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	62% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_441	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_442	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	26% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_443	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_444	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_445	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_446	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_447	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_448	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_449	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_450	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	90% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_451	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	58% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_452	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	74% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_453	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_454	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	28% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_455	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_456	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_457	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_458	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_459	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_460	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_461	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	No	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_462	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	56% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_463	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	58% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_464	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	24% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_465	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_466	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_467	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_468	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_469	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_470	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_471	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_472	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_473	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with CRAd (a deletion adenovirus mutant of 24 nucleotides (Î”24) in the E1A gene)	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	12% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_474	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	30% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_475	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	38% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_476	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	22% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_477	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_478	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	20% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_479	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_480	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	19% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_481	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_482	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_483	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_484	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3ip.1 OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_485	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	No	Viral starin in combination with ING4	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human ovary cancer cell line	SKOV3luc OvCa	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	14% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_1278	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viablity after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1279	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	90% cell viablity after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1280	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	70% cell viabilty after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1281	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1282	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1283	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	70 % cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1284	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	20% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1285	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1286	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	80% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1287	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	50% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1288	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	20% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1289	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1290	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1291	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	90% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1292	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1293	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558

previous12 next